Literature DB >> 8914238

Increased intestinal permeability during cytomegalovirus infection in renal transplant recipients.

E F de Maar1, J H Kleibeuker, W Boersma-van Ek, T H The, W J van Son.   

Abstract

Cytomegalovirus (CMV) infections in renal transplant recipients can affect the gastrointestinal tract, but significant clinical manifestations are seldom seen. We hypothesize that subclinical involvement of the gastrointestinal tract may be quite frequent during CMV infection. In order to study this, we measured intestinal permeability by calculating the urinary lactulose mannitol (LM) excretion ratio after oral administration of lactulose and mannitol (normal < 0.030) in patients with symptomatic and asymptomatic CMV infection. A total of 111 patients were enrolled in the study, 104 of whom were tested on postoperative day (POD) 10. Twenty-nine patients developed CMV infection, 12 of whom could be studied with the permeability test (median POD 40). Another nine patients without CMV infection were also studied at day 40 and served as controls. The LM ratio increased significantly during CMV infection compared to measurements before active infection (median 0.060 vs. 0.030, P < 0.01) and was significantly higher during the infection than in the control group (median 0.007, P < 0.01). No correlation could be found between the LM ratio and viral load, humoral response to the virus, or symptomatology of infection. We conclude that an increased intestinal permeability is found in a substantial number of patients with an active, albeit asymptomatic, CMV infection after renal transplantation. Pathophysiological mechanisms and clinical implications remain speculative but will be subject to further study.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8914238     DOI: 10.1007/bf00335558

Source DB:  PubMed          Journal:  Transpl Int        ISSN: 0934-0874            Impact factor:   3.782


  6 in total

1.  Cytomegalovirus infection increases the risk for inflammatory bowel disease.

Authors:  Robert C Verdonk; Elizabeth B Haagsma; Jan H Kleibeuker; Gerard Dijkstra; Debra L Sudan
Journal:  Am J Pathol       Date:  2010-04-15       Impact factor: 4.307

2.  Cytomegalovirus infection in severe ulcerative colitis patients undergoing continuous intravenous cyclosporine treatment in Japan.

Authors:  Masaaki Minami; Michio Ohta; Teruko Ohkura; Takafumi Ando; Naoki Ohmiya; Yasumasa Niwa; Hidemi Goto
Journal:  World J Gastroenterol       Date:  2007-02-07       Impact factor: 5.742

3.  A sensitive method for quantifying cytomegalic endothelial cells in peripheral blood from cytomegalovirus-infected patients.

Authors:  A M Kas-Deelen; M C Harmsen; E F de Maar; W J van Son; T H The
Journal:  Clin Diagn Lab Immunol       Date:  1998-09

4.  The impact of primary and persistent cytomegalovirus infection on the progression of acute colitis in a murine model.

Authors:  Jerry L Brunson; Felix Becker; Karen Y Stokes
Journal:  Pathophysiology       Date:  2014-11-18

5.  Measurement of the intestinal permeability in chronic kidney disease.

Authors:  Matty L Terpstra; Ramandeep Singh; Suzanne E Geerlings; Frederike J Bemelman
Journal:  World J Nephrol       Date:  2016-07-06

Review 6.  Asymptomatic DNAemia heralds CMV-associated NEC: case report, review, and rationale for preemption.

Authors:  Supatida Tengsupakul; Nicole D Birge; Catherine M Bendel; Robyn C Reed; Beth-Ann Bloom; Nelmary Hernandez; Mark R Schleiss
Journal:  Pediatrics       Date:  2013-10-21       Impact factor: 7.124

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.